Login
$UCL
$0.23 +$0.00 (0.17%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q4 FY2020
As of Dec 31, 2020
Current assets:
Cash and cash equivalents
Accounts receivable, net
Inventories, net
Prepayments and other assets
Amounts due from related parties
Other investments
Total current assets
Non-current assets:
Long-term investments
Property and equipment, net
Right-of-use asset, net
Intangible assets, net
Prepayment
Total non-current assets
Total assets
Current liabilities:
Short term borrowings
Current portion of long-term bank borrowings
Accrued expenses and other liabilities
Accounts payable
Amounts due to related parties
Related Party
Contract liabilities
Operating lease liabilities
Total current liabilities
Non-current liabilities:
Long term borrowings
Operating lease liabilities
Other non-current liabilities
Total non-current liabilities
Total liabilities
Shareholders’ equity:
Ordinary shares, value
Class A ordinary shares
Class B ordinary shares
Additional paid-in capital
Accumulated other comprehensive income
Accumulated losses
Shareholders’ equity
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support